R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Manager – Drug Product - Commercial Manufacturing

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeRedwood City, CA, USA

About the Job

Requirements

  • Bachelor’s or Master’s degree in Pharmaceutical Sciences, Chemical Engineering, Biochemical Engineering, Pharmaceutical Engineering, Chemistry, or a closely related technical discipline.
  • Approximately 6–8 years of relevant pharmaceutical or biotechnology industry experience.
  • Demonstrated commercial drug-product manufacturing experience, including technical operations, manufacturing science, process engineering, or manufacturing support.
  • Experience managing or providing technical oversight to external CMOs or contract manufacturing sites.
  • Strong knowledge of commercial drug-product manufacturing, process and equipment qualification, process validation (PPQ), and Continuous Process Verification (CPV).
  • Working knowledge of cGMP requirements and quality systems, including deviations, CAPA, complaints, change control, and technical documentation.
  • Demonstrated ability to assess manufacturing-site capability, capacity, process fit, equipment needs, and operational risks.
  • Strong communication, technical writing, project-management, and cross-functional collaboration skills; willingness to travel to CMO sites as needed.

Responsibilities

  • Oversee technical transfers, qualification activities, product lifecycle management, and routine commercial manufacturing for assigned commercial products and CMO sites, including drug-product operations involving spray-dried dispersions (SDD), granulation, blending, milling, compression/encapsulation, film coating, and related solid oral dose manufacturing unit operations.
  • Plan and execute transfers; assess process, equipment, and site readiness; develop qualification and validation strategies; monitor ongoing performance; and implement post-approval changes, process improvements, and supply-continuity initiatives throughout the product lifecycle.
  • Serve as the primary technical person for assigned commercial CMOs, providing day-to-day oversight of manufacturing operations, technical performance, and compliance, with particular focus on SDD, granulation, coating, and other critical drug-product unit operations, as applicable.
  • Assess CMO site capability, capacity, facility fit, manufacturing infrastructure, utilities, and readiness to support commercial demand and future product needs.
  • Evaluate and define requirements for manufacturing processes, process equipment, automation, process controls, and other site-specific technical needs.
  • Manage manufacturing technical transfers, including transfer planning, site readiness, process implementation, execution support, and post-transfer monitoring.
  • Manage equipment and process qualification, validation, PPQ, and continued process verification (CPV) activities.
  • Manage manufacturing lifecycle activities, including post-approval changes, process improvements, scale or capacity changes, technical risk mitigation, and supply-continuity initiatives.
  • Manage manufacturing-related deviations, complaints, nonconformances, investigations, root-cause analyses, CAPAs, and change controls.
  • Partner with Quality, Supply Chain, Regulatory, and CMO teams to maintain cGMP compliance, drive continuous improvement, manage documentation including change controls, and prepare for audits and inspections.
  • Support APQRs by authoring appropriate manufacturing sections.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs